Equideum Health has partnered with Nokia Bell Labs to research cognitive augmentation using blockchain combined with AI and edge devices such as earpieces, smartwatches, and home devices.
The joint applied research agenda would be on how they would approach the ethics, identity, cybersecurity, and compliance challenges concerning edge data on all devices, including earables and other remote telemetry devices currently being used, according to Heather Flannery, CEO of Equideum Health.
Nokia has created an earable — a wearable ear gadget with a microphone and speaker – that can utilize on-device machine learning to assist individuals in understanding and responding to the environment around them.
This type of device receives a wide range of very private data, which raises several ethical concerns.
Flannery noted that the concern is whether a guardian or legal representative might opt-in to share data that the patient would not agree to if they were capable of making the decision themself. That’s especially where financial incentives are involved.
She added that they bring improvements in transparency, audio, privacy, and cybersecurity. Improvements over baseline versus further infringement or compromise on the agency and empowerment of the individual.
There have been numerous reports in the media of people in care being mistreated or ignored. Most care facilities contain sensors and monitors, which are also IoT devices,
in addition to wearables. The Equideum Foundation's director, Dr. Pierre Vigilance, pointed out that better data management could assist individuals to get better care.


SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
SpaceX Updates Starlink Privacy Policy to Allow AI Training as xAI Merger Talks and IPO Loom
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Instagram Outage Disrupts Thousands of U.S. Users
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal
Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns
Gold and Silver Prices Slide as Dollar Strength and Easing Tensions Weigh on Metals
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Washington Post Publisher Will Lewis Steps Down After Layoffs
China Extends Gold Buying Streak as Reserves Surge Despite Volatile Prices 



